NCT06163898 2026-04-21A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple MyelomaCelgenePhase 1 Terminated4 enrolled
NCT01081028 2026-04-13Connect® MM- The Multiple Myeloma Disease RegistryCelgeneTerminated3,011 enrolled
NCT04318327 2026-04-01BCMA-directed CAR-T Cell Therapy in Adult Patients With Multiple MyelomaNovartisPhase 1 Terminated96 enrolled